Shares of Regeneron Pharmaceuticals Inc. slipped 4.06% to $634.14 Tuesday, on what proved to be an all-around favorable ...

24th Annual Needham Virtual Healthcare Conference, April 7-10, 2025 Participants may access a live webcast of the event by ...

Q4 2024 Earnings Call Transcript March 25, 2025 X4 Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0 ...

We recently published a list of the 12 Best AI Stocks to Invest in According to Reddit. In this article, we are going to take ...

We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take a look at where Madrigal Pharmaceuticals, Inc.

Jeff Jones; Analyst; Oppenheimer & Co., Inc. Aydin Huseynov; Analyst; Ladenburg Thalmann & Co. Inc. Good afternoon, everyone. Thank you for standing by and welcome to the Corvus Pharmaceuticals ...

WEST CHESTER, Pa., March 26, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ("Verrica” or the "Company”) (Nasdaq: VRCA ...

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, announced it will be presenting a business update today at ...

The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...

X4 Pharmaceuticals, Inc. (XFOR) on Tuesday reported a loss of $39.8 million in its fourth quarter. On a per-share basis, the Boston-based company said it had a loss of ...

AG Kwame Raoul files for approval of a $39.1 million settlement with Apotex Inc. over drug price inflation claims.

Corvus Pharmaceuticals Inc. (CRVS) on Tuesday reported a loss of $12.1 million in its fourth quarter. The Burlingame, California-based company ...